Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleResearch and Reports

Lower Limit of Assay Sensitivity: An Under-recognised and Significant Problem in von Willebrand Disease Identification and Classification

Emmanuel J Favaloro, Roslyn Bonar and Katherine Marsden
American Society for Clinical Laboratory Science July 2008, 21 (3) 178-183; DOI: https://doi.org/10.29074/ascls.21.3.178
Emmanuel J Favaloro
(on behalf of the RCPA QAP Haemostasis Committee) are of the Department of Haematology and RCPA External Quality Assurance Program, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, NSW, Australia
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: emmanuel.favaloro@swahs.health.nsw.gov.au
Roslyn Bonar
(on behalf of the RCPA QAP Haemostasis Committee) are of the Department of Haematology and RCPA External Quality Assurance Program, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, NSW, Australia
B Sc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine Marsden
(on behalf of the RCPA QAP Haemostasis Committee) are of the Department of Haematology and RCPA External Quality Assurance Program, Institute of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, NSW, Australia
FRCPA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 21 no. 3 178-183
DOI 
https://doi.org/10.29074/ascls.21.3.178

Published By 
American Society for Clinical Laboratory Science
Print ISSN 
0894-959X
Online ISSN 
1945-3574
History 
  • Published online July 1, 2008.

Copyright & Usage 
© Copyright 2008 American Society for Clinical Laboratory Science Inc. All rights reserved.

Author Information

PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 21 (3)
American Society for Clinical Laboratory Science
Vol. 21, Issue 3
Summer 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lower Limit of Assay Sensitivity: An Under-recognised and Significant Problem in von Willebrand Disease Identification and Classification
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lower Limit of Assay Sensitivity: An Under-recognised and Significant Problem in von Willebrand Disease Identification and Classification
Emmanuel J Favaloro, Roslyn Bonar, Katherine Marsden
American Society for Clinical Laboratory Science Jul 2008, 21 (3) 178-183; DOI: 10.29074/ascls.21.3.178

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Lower Limit of Assay Sensitivity: An Under-recognised and Significant Problem in von Willebrand Disease Identification and Classification
Emmanuel J Favaloro, Roslyn Bonar, Katherine Marsden
American Society for Clinical Laboratory Science Jul 2008, 21 (3) 178-183; DOI: 10.29074/ascls.21.3.178
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Polyagglutination: Lectin Isolation for T-Activated Red Cells
  • Barriers to Implementation of Quality Management Systems in Laboratories: Lessons from the Southern Africa TB Health Systems Project
  • Strength of Direct Antiglobulin Test as an Indicator of Disease Severity in Autoimmune Hemolytic Anemia
Show more Research and Reports

Similar Articles

Keywords

  • von Willebrand disease
  • von Willebrand Factor, testing
  • VWD, diagnosis, classification, assay variables
  • VWF

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire